Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of Saxagliptin in the newly diagnosed
people with pre-diabetes and obesity besides lifestyle intervention ,there to evaluate DPP 4
inhibitors of reversing pre-diabetes curative effect to normal blood sugar, and observe its
influences on the targets of obesity related metabolic abnormalities, to explore new ways for
intervention on populations with pre-diabetes and obesity .